Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0140-2027

BD Phoenix Panel NMIC-306. Recall

BD Phoenix Panel NMIC-306. Catalog Number: 449292.

FDA recall Class II

Ongoing

FDA lists this Class II recall for BD Phoenix Panel NMIC-306.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0140-2027
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 13, 2026
FDA report date
Oct 21, 2026
Quantity in commerce
669,200 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

BD Phoenix Panel NMIC-306. Catalog Number: 449292.

Affected model & UDI checker

Search the exact identifiers published for Z-0140-2027.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
449292BD Phoenix Panel NMIC-306.Check source noticeNot specified
FDA code information

Catalog Number: 449292. UDI Numbers: (10)5301934(17)26 1102(30)0025(01)3 0382904492923, (10)5301046(17)26 1107(30)0025(01)3 0382904492923, (10)5301019(17)26 1105(30)0025(01)3 0382904492923, (10)5301058(17)26 1108(30)0025(01)3 0382904492923, (10)5301088(17)26 1109(30)0025(01)3 0382904492923, (10)5324448(17)26 1111(30)0025(01)3 0382904492923, (10)5325592(17)26 1122(30)0025(01)3 0382904492923, (10)5336528(17)26 1125(30)0025(01)3 0382904492923, (10)5336554(17)26 1130(30)0025(01)3 0382904492923, (10)5336667(17)26 1203(30)0025(01)3 0382904492923, (10)5336716(17)26 1206(30)0025(01)3 0382904492923, (10)5343520(17)26 1209(30)0025(01)3 0382904492923, (10)5343522(17)26 1221(30)0025(01)3 0382904492923, (10)5350942(17)26 1226(30)0025(01)3 0382904492923, (10)5350876(17)26 1223(30)0025(01)3 0382904492923, (10)5350972(17)26 1228(30)0025(01)3 0382904492923, (10)6006439(17)26 1231(30)0025(01)3 0382904492923, (10)6006497(17)27 0104(30)0025(01)3 0382904492923, (10)6006475(17)27 0103(30)0025(01)3 0382904492923, (10)6013345(17)27 0111(30)0025(01)3 0382904492923, (10)6013300(17)27 0109(30)0025(01)3 0382904492923, (10)6013963(17)27 0118(30)0025(01)3 0382904492923, (10)6013924(17)27 0117(30)0025(01)3 0382904492923, (10)6034519(17)27 0131(30)0025(01)3 0382904492923, (10)6042012(17)27 0203(30)0025(01)3 0382904492923, (10)6042040(17)27 0204(30)0025(01)3 0382904492923, (10)6042153(17)27 0208(30)0025(01)3 0382904492923, (10)6069030(17)27 0309(30)0025(01)3 0382904492923, (10)6082661(17)27 0313(30)0025(01)3 0382904492923, (10)6098326(17)27 0331(30)0025(01)3 0382904492923, (10)6098427(17)27 0405(30)0025(01)3 0382904492923, (10)6104765(17)27 0411(30)0025(01)3 0382904492923, (10)6125411(17)27 0427(30)0025(01)3 0382904492923, (10)6128662(17)27 0430(30)0025(01)3 0382904492923, (10)6138197(17)27 0505(30)0025(01)3 0382904492923, (10)6148207(17)27 0519(30)0025(01)3 0382904492923, (10)6148231(17)27 0520(30)0025(01)3 0382904492923. Lot Numbers: 5301934, 5301046, 5301019, 5301058, 5301088, 5324448, 5325592, 5336528, 5336554, 5336667, 5336716, 5343520, 5343522, 5350942, 5350876, 5350972, 6006439, 6006497, 6006475, 6013345, 6013300, 6013963, 6013924, 6034519, 6042012, 6042040, 6042153, 6069030, 6082661, 6098326, 6098427, 6104765, 6125411, 6128662, 6138197, 6148207, 6148231.

View the original FDA recall notice

Why was this product recalled?

Potential for quality control failures with Klebsiella pneumoniae ATCC BAA-1705 when using the CPO Ambler classification feature.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Becton Dickinson & Co. take?

Beckton Dickenson (BD) notified consignees on about 08/13/2026 via mailed and emailed "URGENT: Medical Device Correction" letter. Clinical users were instructed to do the following: 1. Do not report CPO Ambler classification results generated from affected BD Phoenix CPO detect 6-well panels. 2. Do not release Ambler classification information from BD Phoenix panels on patient reports, laboratory information system reports, electronic health records, or other clinical reporting outputs. 3. CPO positive results, other resistance marker results, and any antimicrobial AST MIC and/or SIR result from the BD Phoenix panels are unaffected and may still be reported according to routine laboratory reporting practice. 4. Confirmatory testing to verify appropriate Ambler Classification should be determined and performed in accordance with established laboratory procedures. 5. There are no recommendations regarding results review or sample retesting. Customers were instructed to ensure the contents of the notification are read and understood, share and post the customer letter within each facility network, forward to any customers to whom product may have been distributed to. Additionally, customers were instructed to complete and return the provided Customer Response Form. BD is investigating the root cause and will implement appropriate corrective actions to rectify this issue as soon as possible. **UPDATE 09/02/2026: Firm expanded recall and sent updated notification to include an additional product code. Instructions remained the same.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology